Equillium to Participate in Upcoming Investor Conferences

LA JOLLA, Calif.--(BUSINESS WIRE)--$EQ--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disord

BusinesswireJul 2 08:00 ET

Investors Don't See Light At End Of Equillium, Inc.'s (NASDAQ:EQ) Tunnel And Push Stock Down 54%

To the annoyance of some shareholders, Equillium, Inc. (NASDAQ:EQ) shares are down a considerable 54% in the last month, which continues a horrid run for the company. Longer-term shareholders will

Simply Wall StJun 16 08:59 ET

Equillium to Be Included in the Russell Microcap Index

LA JOLLA, Calif.--(BUSINESS WIRE)--$EQ--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disord

BusinesswireJun 12 08:00 ET

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business WireJun 5 08:00 ET

H.C. Wainwright Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $5

H.C. Wainwright analyst Ram Selvaraju maintains $Equillium(EQ.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 36.8% and a tot

moomoo NewsJun 5 06:33 ET

Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings

U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 200 points on Tuesday.The Dow traded up 0.53% to 38,774.55 while the NASDAQ rose 0.29% to 16,877.87. The S&P 500

BenzingaJun 4 14:32 ET